Thomas A. Edwards, Director at ChemoCentryx, Inc. (CCXI), sold 400 shares at $70.04 ($28K) on 2021-02-09, disclosed to the SEC on 2021-02-11.
Scheduled sale ($28k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CCXI | SELL | 2020-12-29 | $2.4M | — | Filing → |
| CCXI | BUY | 2016-05-18 | $203K | — | Filing → |
| CCXI | BUY | 2016-05-16 | $101K | — | Filing → |